We have assessed the reliability of pCASL using 3D TSE-CASPR in healthy volunteers and glioblastoma (GBM) patients. “Excellent” agreement was observed for intrasession reliability in both normal appearing grey matter (NAGM) and tumors with intraclass correlation coefficient (ICC) of 0.945 (95% CI: 0.916-0.964) and 0.948 (95% CI: 0.883-0.978) respectively. Across multiple ROIs, the within-subject coefficient of variation (wsCV) was measured to be 6.1 ± 1.2% across all subjects in NAGM, and 5.1% in tumors. The lower wsCV in tumors allow 3D TSE pCASL using CASPR to be used for longitudinal monitoring of GBM patients.
This abstract and the presentation materials are available to members only; a login is required.